Author

Christian Englisch

Institution: Janssen (Germany)

Observed institution: Janssen (Germany)

OpenAlex ID: A5030952116

Indirect Comparison Using Individual Patient Level Data Comparing Efficacy and Safety of a Daratumumab Monotherapy Vs. EU Approved Comparator Therapies in Patients with Multiple Myeloma

2018 · Irina Demmer, Susanne Huschens, et al. · Blood · 1

Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First‐Line Treatment in Patients With Newly Diagnosed Non‐Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study

2026 · Eyck von der Heyde, Marcel Reiser, et al. · European Journal Of Haematology

Works count: 2

Citation count: 1

H-index: 1

I10-index: